Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days £260.00 £353.00 Friday, 10th May 2024 HCM.L stock ended at £352.00. This is 13.55% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 3.22% from a day low at £342.00 to a day high of £353.00.
90 days £202.50 £353.00
52 weeks £173.60 £353.00

Historical Hutchison China Meditech Ltd ADR (Sponsored) prices

Date Open High Low Close Volume
Jul 26, 2023 £224.00 £226.70 £215.71 £226.00 34 859
Jul 25, 2023 £205.00 £223.00 £205.00 £217.25 56 307
Jul 24, 2023 £203.20 £210.70 £194.00 £207.75 47 065
Jul 21, 2023 £196.80 £200.52 £196.45 £200.00 16 883
Jul 20, 2023 £196.32 £196.80 £189.93 £193.60 13 913
Jul 19, 2023 £193.00 £204.50 £193.00 £200.85 1 435
Jul 18, 2023 £193.20 £199.80 £193.20 £199.80 13 303
Jul 17, 2023 £198.06 £203.81 £193.74 £201.05 712
Jul 14, 2023 £197.20 £203.64 £197.20 £200.55 2 274
Jul 13, 2023 £195.80 £203.50 £195.80 £198.20 26 224
Jul 12, 2023 £193.40 £198.40 £189.62 £196.30 7 022
Jul 11, 2023 £196.00 £199.08 £193.60 £193.60 2 821
Jul 10, 2023 £193.00 £193.00 £193.00 £193.00 0
Jul 07, 2023 £188.24 £193.00 £186.00 £193.00 12 298
Jul 06, 2023 £191.42 £197.91 £190.60 £193.60 1 813
Jul 05, 2023 £197.20 £204.50 £188.20 £193.80 14 179
Jul 04, 2023 £195.00 £207.00 £195.00 £202.60 51 227
Jul 03, 2023 £189.00 £189.00 £189.00 £189.00 0
Jun 30, 2023 £185.80 £194.60 £185.80 £189.00 142 140
Jun 29, 2023 £184.83 £184.83 £176.96 £179.60 2 238
Jun 28, 2023 £179.20 £183.90 £174.20 £180.30 45 886
Jun 27, 2023 £180.40 £183.78 £179.20 £179.20 13 426
Jun 26, 2023 £179.80 £184.00 £175.33 £184.00 32 874
Jun 23, 2023 £179.00 £182.76 £173.60 £173.60 34 037
Jun 22, 2023 £183.80 £183.80 £175.38 £180.00 43 692
Click to get the best stock tips daily for free!

About Hutchison China Meditech Ltd ADR (Sponsored)

Hutchison China Meditech Ltd ADR (Sponsored) HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and renal cell carcinoma, colorectal cancer (CRC), and gastric cancer (GC); and Fruquintinib, an inhibitor for ... HCM.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT